References

Assayag, Jonathan et al. 2013. “The Impact of the Type of Insurance Plan on Adherence and Persistence with Antidepressants: A Matched Cohort Study.” Canadian Journal of Psychiatry. Vol. 58, no. 4, pp. 233–39.

Ayodele, Busola, Elaine X. Guo, Arthur Sweetman and G. Emmanuel Guindon. 2022. “Inequity in insurance coverage for prescription drugs in New Brunswick, Canada.” Canadian Journal of Public Health. Vol. 113, no. 4, pp. 504-518.

Barua, Bacchus, David Jacques and Nadeem Esmail. 2018. Provincial Drug Coverage for Vulnerable Canadians. Fraser Institute.

Bolatova, Talshyn and Michael R. Law. 2019. “Income-related disparities in private prescription drug coverage in Canada.” Canadian Medical Association Open Access Journal. Vol 7, no. 4, pp. E618-E623.

Chamoun, M., A. Forget, I. Chabot, M. Schnitzer and L. Blais. 2022. “Difference in drug cost between private and public drug plans in Quebec, Canada.” BMC Health Services Research. Vol 22, no. 200.

Cortes, Kassandra and Leah Smith. 2022. “Pharmaceutical access and use during the pandemic.” Insights on Canadian Society. Statistics Canada Catalogue no. 75-006-X.

Després, François, Amélie Forget, Fatima-Zohra Kettani and Lucie Blais. 2016. “Impact of patient reimbursement timing and patient out-of-pocket expenses on medication adherence in patients covered by private drug insurance plans.” Journal of Managed Care & Specialty Pharmacy. Vol. 22, no. 5, pp. 539-547.

Government of Canada. 2019. Final Report of The Advisory Council on the Implementation of National Pharmacare: A Prescription for Canada: Achieving Pharmacare for All – Final Report of the Advisory Council on the Implementation of National Pharmacare. Health Canada.

Government of Canada. 2021. “Measuring What Matters: Toward a Quality of Life Strategy for Canada.” Department of Finance Canada.

Gupta, Shikha, Mary Ann McColl, Sara J. Guilcher and Karen Smith. 2019. “Managing Medication Cost Burden: A Qualitative Study Exploring Experiences of People with Disabilities in Canada.” International Journal of Environmental Research and Public Health. Vol. 16, no. 17, p. 3066.

Gupta, Shikha, Mary Ann McColl, Sara J. Guilcher and Karen Smith. 2018. “Cost-related non-adherence to prescription medications in Canada: a scoping review.” Patient Preference and Adherence. Vol. 12, pp. 1699–1715.

Kolhatkar, Ashra, Lucy Cheng, Steven G. Morgan et al. 2018. “Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis. CMAJ Open. Vol. 6, no. 4, pp. E544-E550.

Kratzer, Jillian, Lucy Cheng, Sara Allin, Michael R. Law. 2015. “The impact of private insurance coverage on prescription drug use in Ontario, Canada.” Healthcare Policy. Vol. 10, no. 4, pp. 62-74.

Law, Michael R., Lucy Cheng, Ashra Kolhatkar et al. 2018. “The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.” CMAJ Open. Vol. 6, no. 1, pp. E63-E70.

Millar, W. J. 1999. “Disparities in prescription drug insurance coverage.” Health Reports. Vol. 10, no. 4, pp. 11-31.

Morgan, Steven G. and Augustine Lee. 2017. “Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.” BMJ Public Health. Vol. 7, no. 1.

Statistics Canada. 2021 (June 28). “Prescription medication use among Canadian adults, 2016 to 2019.” The Daily.